Gut microbiota-derived short-chain fatty acids regulate group 3 innate lymphoid cells in HCC.
Chupeng HuBingqing XuXiaodong WangWen-Hua WanJinying LuDeyuan KongYu JinWenhua YouHua SunXiaoxin MuDongju FengYun ChenPublished in: Hepatology (Baltimore, Md.) (2022)
These findings suggested that modifying bacteria, changing SCFAs, reducing IL-17A-producing ILC3 infiltration, and combining with immune checkpoint inhibitors will contribute to the clinical treatment of HCC.